Bio2Electric, LLC, dba EcoCatalytic Technologies, is collaborating with North Carolina State University, among other industry partners,to develop a new catalyst technology to produce ethylene and propylene from natural gas.
NC State will head catalyst development and bench scale testing under Dr. Fanxing Li, an assistant professor of chemical and biomolecular engineering. Key personnel include Dr. Luke Neal, a postdoctoral research scholar, and graduate research associates.
SEE ALSO: Researchers to Turn Methane Into Liquid Fuel
“Our work will focus on a novel redox catalyst that has shown promise to enhance yield of ethylene and propylene while reducing emissions,” said Dr. Fanxing Li.
Ethylene and propylene are major building blocks in the organic chemical industry, with more than 750 million tons per year produced globally and transformed into plastics such as PE, PP and PET—which are ultimately used in thousands of consumer products.
“The confluence of low cost natural gas in the U.S. and the need to reduce environmental emissions provides significant opportunity for innovation,” said EcoCatalytic Technologies CEO Dr. John Sofranko.
The current technologies for ethylene and propylene production are energy intensive and emit more than 1.5 tons of carbon dioxide for every ton of ethylene or propylene produced. The new technology is anticipated to reduce the CO2 footprint by more than 90% and eliminate the release of nitrogen oxide (NOx) and sulfur oxide (SOx) pollutants.
Bio2Electric, LLC, dba EcoCatalytic Technologies, received a three-year, $3.8 million award from the U.S. Department of Energy’s Advanced Research Projects Agency-Energy (ARPA-E) to develop a new catalyst technology for ethylene and propylene production from components of natural gas. NC State’s work will be funded by $1.29 million of the grant.
Bio2Electric is an early stage start-up company developing technologies for the conversion of natural and bio based gas to sustainable supplies of liquid fuels and electrical power. It was formed in 2009 as a partnership between TreadStone Technologies, Inc. and Bio2Electric’s founder, Dr. John Sofranko